August 4, 2017
HAWTHORNE, N.Y., United States
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2017, after the close of market on Tuesday, August 8, 2017. Consistent with the Company’s policy, Taro will conduct its next earnings call when it announces its financial results for the six months ending September 30, 2017.
The release will be accessible on Taro’s website at www.taro.com.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.